Abstract
The immune system and the nervous system maintain extensive communication, including 'hardwiring' of sympathetic and parasympathetic nerves to lymphoid organs. Neurotransmitters such as acetylcholine, norepinephrine, vasoactive intestinal peptide, substance P and histamine modulate immune activity. Neuroendocrine hormones such as corticotropin-releasing factor, leptin and α-melanocyte stimulating hormone regulate cytokine balance. The immune system modulates brain activity, including body temperature, sleep and feeding behavior. Molecules such as the major histocompatibility complex not only direct T cells to immunogenic molecules held in its cleft but also modulate development of neuronal connections. Neurobiologists and immunologists are exploring common ideas like the synapse to understand properties such as memory that are shared in these two systems.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steinman, L. Connections between the immune system and the nervous system. Proc. Natl. Acad. Sci. USA 90, 7912–7914 (1993).
Felten, S.Y. et al. Noradrenergic sympathetic innervation of lymphoid organs. Prog. Allergy 43, 14–36 (1988).
Livnat, S., Felten, S.Y., Carlson, S.L., Bellinger, D.L. & Felten, D.L. Involvement of peripheral and central catecholamine systems in neuroimmune interactions. J. Neuroimmunol. 10, 5–30 (1985).
Steinman, L., Conlon, P., Maki, R. & Foster, A. The intricate interplay among body weight, stress and the immune response to friend or foe. J. Clin. Invest. 111, 183–185 (2003).
Blatteis, C.M. The afferent signaling of fever. J. Physiol. 526, 470 (2000).
Li, S., Goorha, S., Ballou, L.R. & Blatteis, C.M. Intracerebroventricular interleukin 6, macrophage inflammatory protein 1β and IL-18: pyrogenic and PGE(2)-mediated? Brain Res. 992, 76–84 (2003).
Engblom, D. et al. Prostaglandins as inflammatory messengers across the blood brain barrier. J. Mol. Med. 80, 5–15 (2002).
Goehler, L.E. et al. Interleukin-1β in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? J. Neurosci. 19, 2799–2806 (1999).
Mosmann, T.R. & Coffman, R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145–73 (1989).
Wekerle, H. Tackling multiple sclerosis. Nature 420, 39–40 (2002).
Steinman, L., Martin, R., Bernard, C.C.A., Conlon, P. & Oksenberg, J.R. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25, 491–505 (2002).
Zamvil, S. & Steinman, L. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron 38, 685–688 (2003).
Youssef, S. et al. The HMG-CoA reductase inhibitor, atorvastatin, promotes a TH2 bias and reverses paralysis in CNS autoimmune disease. Nature 420, 78–84 (2002).
Frankel, J. et al. Lack of isoprenoid products raises ex vivo interleukin 1β secretion in hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum. 46, 2794–2803 (2002).
Cartmell, T., Ball, C., Bristow, A.F., Mitchell, D. & Poole, S. Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats. J. Physiol. 549, 653–664 (2003).
Boneberg, E.M. & Hartun, T. Febrile temperatures attenuate IL-1β release by inhibiting proteolytic processing of the proform and influence TH1/TH2 balance by favoring TH2 cytokines. J. Immunol. 171, 664–668 (2003).
Tracey, K.J. The inflammatory reflex. Nature 420, 853–859 (2002).
Borovikova, L.V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458–462 (2000).
Woiciechowsky, C. et al. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 4, 808–813 (1998).
Sanders, V.M. et al. Differential expression of the β2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. J. Immunol. 158, 4200–4210 (1997).
Miller, L.E., Grifka, J., Scholmerich, J. & Straub, R.H. Norepinephrine from synovial tyrosine hydroxylase positive cells is a strong indicator of synovial inflammation in rheumatoid arthritis. J. Rheumatol. 29, 427–435 (2002).
Voice, J.K. et al. Roles of vasoactive intestinal peptide (VIP) in the expression of different immune phenotypes by wild-type mice and T cell-targeted type II VIP receptor transgenic mice. J. Immunol. 170, 308–314 (2003).
Grimm, M.C. et al. Vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors. J. Immunol. 171, 4990–4994 (2003).
Martinez, C. et al. Anti-inflammatory role in septic shock of pituitary adenylate cyclase-activating polypeptide receptor. Proc. Natl. Acad. Sci. USA 99, 1053–1058 (2002).
Brain, S.D. & Williams, T.J. Substance P regulates the vasoldilator activity of calcitonin gene-related peptide. Nature 335, 73–75 (1988).
Steinhoff, M. et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat. Med. 6, 151–158 (2000).
Pedotti, R. et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide. Nat. Immunol. 2, 216–222 (2001).
Jutel, M. et al. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors. Nature 413, 420–425 (2001).
Poliak, S. et al. Stress and autoimmunity: The neuropeptides corticotropin releasing factor and urocortin suppress encephalomyelitis via effects on both the hypothalamic-pituitary-adrenal axis and the immune system. J. Immunol. 158, 5751–5756 (1997).
Grabbe, S. et al. α-Melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J. Immunol. 156, 473–478 (1996).
Streilein, J.W., Okamoto, S., Sano, Y. & Taylor, A.W. Neural control of ocular immune privilege. Ann. NY Acad. Sci. 917, 297–306 (2000).
Fekete, C. & Liposits, Z. Histamine-immunoreactive neurons of the tuberomammillary nucleus are innervated by α-melanocyte stimulating hormone-containing axons. Brain Res. 969, 70–77 (2003).
Matarese, G. et al. Requirement for leptin in induction and progression of experimental autoimmune encephalomyelitis. J. Immunol. 166, 5909–5916 (2001).
Sanna, V. et al. Leptin surge precedes autoimmune encephalomyelitis and correlates with disease susceptibility, inflammatory anorexia and the development of pathogenic T cell responses. J. Clin. Invest. 111, 241–250 (2003).
Baumann, H. et al. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors. Proc. Natl. Acad. Sci. USA 93, 8374–8378 (1996).
Demas, G.E. Splenic denervation blocks leptin-induced enhancement of humoral immunity in Siberian hamsters (Phodopus sungorus). Neuroendocrinology 76, 178–84 (2002).
Rayner, D.V. & Trayhurn, P. Regulation of leptin production: sympathetic nervous system interactions. J. Mol. Med. 79, 8–20 (2001).
Prinz, M. et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957–62 (2003).
Prinz, M. et al. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc. Natl. Acad. Sci. USA 99, 919–924 (2002).
Malamud, V. et al. Tryptase activates peripheral blood mononuclear cells causing the synthesis and release of TNF, IL-6 and IL-1: possible relevance to multiple sclerosis. J. Neuroimmunol. 138, 115–122 (2003).
Lock, C. et al. Gene microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8, 500–508 (2002).
Pedotti, R. et al. Multiple elements of the allergic arm of the immune response modulate autoimmune demyelination. Proc. Natl. Acad. Sci. USA 100, 1867–1872 (2003).
Pedotti, R., DeVoss, J., Steinman, L. & Galli, S. Involvement of both 'allergic' and 'autoimmune' mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24, 479–484 (2003).
Woolley, D.E. & Tetlow, L.C. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion. Arthr. Res. 2, 65–74 (2000).
Tanzola, M.B., Robbie-Ryan, M., Gutekunst, C.A. & Brown, M.A. Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J. Immunol. 171, 4385–4391 (2003).
Benoist, C. & Mathis, D. Mast cells in autoimmune disease. Nature 420, 875–878 (2002).
Lee, D.M. et al. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297, 1689–1692 (2002).
Tracey, K.J. et al. Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167, 1211–1227 (1988).
Webster, E.L. et al. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J. Rheumatol. 29, 1252–1261 (2002).
Dhabhar, F.S., Satoskar, A.R., Bluethmann, H., David, J.R. & McEwen, B.S. Stress-induced enhancement of skin immune function: a role for γ interferon. Proc. Natl. Acad. Sci. USA 97, 2846–2851 (2000).
Ader, R. & Cohen, N. Behaviorally conditioned immunosuppression. Psychosomatic Med. 37, 333–340 (1975).
Ader, R. & Cohen, N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 215, 1534–1536 (1982).
Rogers, S.W. et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265, 648–651 (1994).
Counce, D., Limdi, N. & Kuzniecky, R. Rasmussen's encephalitis. Curr. Treat. Options Neurol. 3, 555–563 (2001).
Darnell, R.B. & Posner, J.B. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 349, 1543–1554 (2003).
Solimena, M., Folli, F., Aparisi, R., Pozza, G. & De Camilli, P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N. Engl. J. Med. 322, 1555–1560 (1990).
Baekkeskov, S. et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347, 151–156 (1990).
Rosin, L. et al. Stiff-man syndrome in a woman with breast cancer: an uncommon central nervous system paraneoplastic syndrome. Neurology 50, 94–98 (1998).
Sakai, K., Mitchell, D., Tsukamoto, T. & Steinman, L. Isolation of a complementary cDNA clone encoding an autoantigen recognized by an anti-neuronal antibody from a patient with paraneoplastic cerebellar degeneration. Ann. Neurol. 28, 692–698 (1990).
Lennon, V.A. & Carnegie, P.R. Immunopharmacological disease: a break in tolerance to receptor sites. Lancet 1, 630–633 (1971).
Patrick, J. & Lindstrom, J. Autoimmune response to acetylcholine receptor. Science 180, 871–872 (1973).
Engel, A.G., Tsujihata, M., Lambert, E.H., Lindstrom, J.M. & Lennon, V.A. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations. J. Neuropathol. Exp. Neurol. 35, 569–587 (1976).
Drachman, D.B., Angus, C.W., Adams, R.N., Michelson, J.D. & Hoffman, G.J. Myasthenic antibodies cross-link acetylcholine receptors to accelerate degradation. N. Engl. J. Med. 298, 1116–1122 (1978).
Steinman, L. & Mantegazza, R. The prospects for specific immunotherapy in myasthenia gravis. FASEB J. 4, 2726–2731 (1990).
Fetissov, S.O. et al. Autoantibodies against α-MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc. Natl. Acad. Sci. USA 99, 17155–17160 (2002).
Steinman, L. Multiple sclerosis: A two stage disease. Nat. Immunol. 2, 762–765 (2001).
McGeer, E.G. & McGeer, P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27, 741–749 (2003).
Imamura, K. et al. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol (Berl) 106, 518–526 (2003).
Moalem, G. et al. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49–55 (1999).
Chabas, D. et al. The influence of the pro-inflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 294, 1731–1735 (2001).
Karpuj, M.V. et al. Prolonged survival and decreased abnormal movements in transgenic model of Huntington's disease, with administration of cystamine, a transglutaminase Inhibitor. Nat. Med. 8, 143–149 (2002).
Kerschensteiner, M., Stadelmann, C., Dechant, G., Wekerle, H. & Hohlfeld, R. Neurotrophic cross-talk between the nervous and immune systems: implications for neurological diseases. Ann. Neurol. 53, 292–304 (2003).
Villoslada, P. et al. Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system. J. Exp. Med. 191, 1799–1806 (2000).
Feldmann, M. & Maini, R.N. Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat. Med. 9, 1245–1250 (2003).
Arnett, H.A. et al. TNF-α promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4, 1116–1122 (2001).
Pluchino, S. et al. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422, 688–694 (2003).
Steinman, L. Collateral damage repaired. Nature 422, 671–672 (2003).
Yednock, T. et al. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4β1 integrin. Nature 356, 63–66 (1992).
Hood, L., Kronenberg, M. & Hunkapiller, T. T cell antigen receptors and the immunoglobulin supergene family. Cell 40, 225–229 (1985).
Huh, G.S. et al. Functional requirement for class I MHC in CNS development and plasticity. Science 290, 2155–2159 (2000).
Joly, E., Mucke, L. & Oldstone, M.B. Viral persistence in neurons explained by lack of major histocompatibility I expression. Science 253, 11283–11285 (1991).
Neumann, H., Cavalie, A., Jenne, D.E. & Wekerle, H. Induction of MHC class I genes in neurons. Science 269, 549–552 (1995).
Steinman, L. The unexpected benefits of stealth. Neurology 42, 276–277 (1992).
Syken, J. & Schatz, C. Expression of T cell receptor β locus in central nervous system neurons. Proc. Natl. Acad. Sci. USA 100, 13048–13053 (2003).
Loconto, J. et al. Functional expression of murine V2R pheromone receptors involves selective association with the M10 and M1 families of MHC class Ib molecules. Cell 112, 607–618 (2003).
Ishii, T., Hirota, J. & Mombaerts, P. Combinatorial coexpression of neural and immune multigene families in mouse vomeronasal sensory neurons. Curr. Biol. 13, 394–400 (2003).
Kumanogoh, A. et al. Class IV semaphorin Sema4A enhances T cell activation and interacts with Tim-2. Nature 419, 629–633 (2002).
Kuchroo, V.K., Umetsu, D.T., DeKruyff, R.H. & Freeman, G.J. The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 3, 454–462 (2003).
Ueda, R & Sugiyama, S. Nerve impulse in the 19th century: it's nature and the method of research. Kgakushi Kenkyhu 42, 76–87 (2003).
Norcross, M.A. A synaptic basis for T-lymphocyte activation. Ann. Immunol. (Paris) 135, 113–134 (1984).
Huppa, J.B. & Davis, M.M. T-cell-antigen recognition and the immunological synapse. Nat. Rev. Immunol. 3, 973–83 (2003).
Dustin, M.L. & Colman, D.R. Neural and immunological synaptic relations. Science 298, 785–789 (2002).
Irvine, D., Purbhoo, M., Krogsgaard, M. & Davis, M.M. Direct observation of ligand recognition by T cells. Nature 419, 845–849 (2002).
Baylor, D.A., Lamb, T.D. & Yau, K.W. Responses of retinal rods to single photons. J. Physiol. (Lond.) 288, 613–634 (1979).
Acknowledgements
Supported by the National Institutes of Health and the Phil N. Allen Trust.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Steinman, L. Elaborate interactions between the immune and nervous systems. Nat Immunol 5, 575–581 (2004). https://doi.org/10.1038/ni1078
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1078
This article is cited by
-
Understanding immunity: an alternative framework beyond defense and strength
Biology & Philosophy (2023)
-
N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes
Journal of Neuroinflammation (2022)
-
Association of stress management skills and stressful life events with allergy risk: a case-control study in southern China
BMC Public Health (2021)
-
Reduced vagal tone in women with endometriosis and auricular vagus nerve stimulation as a potential therapeutic approach
Scientific Reports (2021)
-
Permeability of the windows of the brain: feasibility of dynamic contrast-enhanced MRI of the circumventricular organs
Fluids and Barriers of the CNS (2020)